Arm Stock Drops 6% on Morgan Stanley Downgrade
Get the Finance newsletter
Daily finance — markets, central banks, M&A, the prints that move money. Free.
- Arm Holdings shares fell about 6% in midday trading on Tuesday after Morgan Stanley's Lee Simpson downgraded the stock to equal weight from overweight, citing risks that could stall a rally driven by the company's new push to sell its own CPUs.
- Arm had surged nearly 40% from its February lows on enthusiasm around its announced shift into selling its own central processing units, a move that would expand the company beyond chip-design licensing and royalties into the broader CPU market.
- Morgan Stanley flagged the ongoing industrywide DRAM chip shortage as a threat to Arm's royalty business, warning that consumer-electronics makers struggling with chip supply and rising memory prices would produce fewer royalty-generating devices.
- Simpson highlighted Arm's litigation with Qualcomm, noting that a recent ruling could limit Arm's ability to charge higher royalty rates and that a second round of litigation between the two poses additional downside risk.
- Arm's CPU pivot could put the company in direct competition with its own chip-making customers, Simpson warned, though he noted that Nvidia and Apple hold long-term licensing agreements likely to remain intact, with smaller CPU customers most at risk of reducing Arm reliance.
- Simpson acknowledged the CPU strategy is 'strategically sound' and said the long-term case 'remains compelling,' but the downgrade — coming after multiple recent Wall Street upgrades — underscores execution, competitive, and cyclical risks tied to the transition.
Why it matters: Arm's stock had become a consensus Wall Street favorite, with several analysts upgrading shares in recent weeks; Morgan Stanley's downgrade — driven by royalty pressure from the DRAM shortage, the Qualcomm legal fight, and customer-alienation risk from the CPU pivot — is a notable contrarian signal. With shares already correcting 6% on the call, smaller CPU customers who lack long-term licensing pacts face the most concrete exposure as Arm's strategy potentially reshapes its own ecosystem.
Ask SkimNews
